Keywords: mail-order, rxs, boost, searle/pfizer, celebrex, week, ending
Mail-order Rxs boost Searle/Pfizer Celebrex
Article | 16 March 1999
For the week ending March 5, 263,809 US prescriptions were dispensed forSearle/Pfizer's COX-2 inhibitor Celebrex (celecoxib), up 16% from the previous week, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
